Encompass Health Corporation (NYSE:EHC) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Encompass Health Corporation (NYSE:EHC) has been assigned a consensus recommendation of “Moderate Buy” from the nine analysts that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $143.8571.

Several analysts recently issued reports on EHC shares. Weiss Ratings downgraded shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, June 26th. Barclays dropped their target price on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th. TD Cowen assumed coverage on shares of Encompass Health in a research report on Thursday, May 28th. They set a “buy” rating and a $125.00 target price for the company. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Finally, Leerink Partners set a $152.00 price target on Encompass Health in a research report on Friday, May 22nd.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the sale, the executive vice president owned 24,755 shares of the company’s stock, valued at $2,588,382.80. This trade represents a 2.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.80% of the stock is owned by company insiders.

Institutional Investors Weigh In On Encompass Health

Hedge funds have recently modified their holdings of the business. Royal Bank of Canada increased its position in Encompass Health by 21.5% during the first quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after acquiring an additional 15,677 shares during the period. Millennium Management LLC boosted its holdings in Encompass Health by 38.4% in the 1st quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock valued at $9,338,000 after purchasing an additional 25,574 shares during the period. Caxton Associates LLP acquired a new stake in Encompass Health in the 1st quarter worth $259,000. Walleye Capital LLC increased its holdings in shares of Encompass Health by 667.6% during the 2nd quarter. Walleye Capital LLC now owns 6,522 shares of the company’s stock worth $800,000 after purchasing an additional 7,671 shares during the period. Finally, Gamco Investors INC. ET AL bought a new position in shares of Encompass Health during the 2nd quarter worth about $588,000. 97.25% of the stock is owned by institutional investors.

Encompass Health Stock Up 0.0%

EHC opened at $106.48 on Friday. The business has a 50 day moving average price of $103.10 and a 200 day moving average price of $103.43. Encompass Health has a twelve month low of $92.77 and a twelve month high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. The firm has a market cap of $10.56 billion, a P/E ratio of 17.78, a price-to-earnings-growth ratio of 2.32 and a beta of 0.74.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, beating the consensus estimate of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The company had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter last year, the company posted $1.37 earnings per share. The company’s revenue for the quarter was up 9.0% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Research analysts forecast that Encompass Health will post 5.97 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a dividend of $0.19 per share. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio is presently 12.69%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.